New Data on Subcutaneous Bortezomib | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

New Data on Subcutaneous Bortezomib

Acta Haematol (2014) 133 (1): 26–28.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Carfilzomib–dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study

Hartmut Goldschmidt
Philippe Moreau
Heinz Ludwig
Ruben Niesvizky
Wee-Joo Chng
Douglas Joshua
Katja Weisel
Andrew Spencer
Robert Z. Orlowski
Shibao Feng
Karim S. Iskander
Meletios A. Dimopoulos

Leukemia & Lymphoma (2018) 59 (6): 1364.